Cargando…

Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord

A pathological pathway leading from soluble monomeric to insoluble filamentous Tau is characteristic of many human neurodegenerative diseases, which also exhibit dysfunction and death of brain cells. However, it is unknown how the assembly of Tau into filaments relates to cell loss. To study this, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macdonald, Jennifer A., Bronner, Iraad F., Drynan, Lesley, Fan, Juan, Curry, Annabelle, Fraser, Graham, Lavenir, Isabelle, Goedert, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421678/ https://www.ncbi.nlm.nih.gov/pubmed/30885267 http://dx.doi.org/10.1186/s40478-019-0695-5

Ejemplares similares

Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau
por: Schweighauser, Manuel, et al.
Publicado: (2023)

Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
por: Ozcelik, Sefika, et al.
Publicado: (2013)

Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice
por: Hoffmann, Nadine A, et al.
Publicado: (2013)

Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice
por: Clavaguera, Florence, et al.
Publicado: (2013)

Tauopathy-induced retinal dysfunction in the P301S mutant human tau transgenic mouse
por: Mazzaro, Nadia, et al.
Publicado: (2013)

Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice
por: Höllerhage, Matthias, et al.
Publicado: (2014)

Silver staining (Campbell-Switzer) of neuronal α-synuclein assemblies induced by multiple system atrophy and Parkinson’s disease brain extracts in transgenic mice
por: Lavenir, Isabelle, et al.
Publicado: (2019)

Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic Mice
por: Schön, Christian, et al.
Publicado: (2012)

Reduced Axonal Transport and Increased Excitotoxic Retinal Ganglion Cell Degeneration in Mice Transgenic for Human Mutant P301S Tau
por: Bull, Natalie D., et al.
Publicado: (2012)

Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy
por: Schaeffer, Véronique, et al.
Publicado: (2012)

Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene]
por: Velasco, Ana, et al.
Publicado: (2008)

Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
por: Hosokawa, Masato, et al.
Publicado: (2012)

Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice
por: Ohia-Nwoko, Odochi, et al.
Publicado: (2014)

Correction: Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice
Publicado: (2015)

Altered sleep and EEG power in the P301S Tau transgenic mouse model
por: Holth, Jerrah K., et al.
Publicado: (2017)

Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice
por: Zhong, Suyue, et al.
Publicado: (2023)

Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds
por: Macdonald, Jennifer A., et al.
Publicado: (2021)

Beta-sheet assembly of Tau and neurodegeneration in Drosophila melanogaster
por: Passarella, Daniela, et al.
Publicado: (2018)

Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
por: Bi, Mian, et al.
Publicado: (2011)

Biochemical Distribution of Tau Protein in Synaptosomal Fraction of Transgenic Mice Expressing Human P301L Tau
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Longitudinal evaluation of Tau‐P301L transgenic mice reveals no cognitive impairments at 17 months of age
por: Kent, Brianne A., et al.
Publicado: (2017)

Increase in Tau Pathology in P290S Mapt Knock-In Mice Crossed with App(NL-G-F) Mice
por: Huang, Melissa, et al.
Publicado: (2022)

Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
por: Eckenweber, Florian, et al.
Publicado: (2020)

The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
por: Valencia, Antonio, et al.
Publicado: (2021)

Alteration in the Synaptic and Extrasynaptic Organization of AMPA Receptors in the Hippocampus of P301S Tau Transgenic Mice
por: Alfaro-Ruiz, Rocio, et al.
Publicado: (2022)

Correction to: The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

Antileukotriene therapy by reducing tau phosphorylation improves synaptic integrity and cognition of P301S transgenic mice
por: Giannopoulos, Phillip F., et al.
Publicado: (2018)

Contribution of endogenous antibodies to learning deficits and astrocytosis in human P301S mutant tau transgenic mice
por: van der Hoven, Julia, et al.
Publicado: (2020)

Different modes of synaptic and extrasynaptic NMDA receptor alteration in the hippocampus of P301S tau transgenic mice
por: Alfaro‐Ruiz, Rocío, et al.
Publicado: (2022)

The fluorescent pentameric oligothiophene pFTAA identifies filamentous tau in live neurons cultured from adult P301S tau mice
por: Brelstaff, Jack, et al.
Publicado: (2015)

Commentary: Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice
por: Betts, Matthew J., et al.
Publicado: (2018)

Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
por: Chang, Yanmin, et al.
Publicado: (2021)

The Change in Circadian Rhythms in P301S Transgenic Mice is Linked to Variability in Hsp70-related Tau Disaggregation
por: Han, Song Mi, et al.
Publicado: (2022)

Late neurodegeneration in the Tau transgenic mouse model rTg4510
por: Helboe, Lone, et al.
Publicado: (2013)

Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer’s Disease Like Tau Aggregation
por: Richter, Monique, et al.
Publicado: (2014)

P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice
por: Ruan, Zhi, et al.
Publicado: (2020)

Corrigendum: Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
por: Chang, Yanmin, et al.
Publicado: (2021)

P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating
por: Takeuchi, Hiroki, et al.
Publicado: (2011)

α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice
por: Zhang, Yan-Hui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i219se8j7gcfjrhjairbu4b8or